Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Glaxosmithkline (GSK) Share News

LONDON MARKET CLOSE: Stocks slide, oil jumps after Israel strikes Iran

13th Jun 2025 17:06

(Alliance News) - The oil price soared and stocks slumped on Friday after Israel launched dozens of air strikes against Iran, ramping up tensions in the Middle East. Read More

GSK's RSV drug Arexvy accepted for regulatory review in Europe

13th Jun 2025 08:14

(Alliance News) - GSK PLC on Friday said its respiratory syncytial virus vaccine, Arexvy, has been accepted for regulatory review by the European Medicines Agency to expand its use in adults 18 years and older. Read More

CORRECT: PHP hits back after Assura backs KKR offer

13th Jun 2025 07:58

(Correcting currency of bid for Adriatic Metals.) Read More

LONDON BRIEFING: PHP hits back after Assura backs KKR offer

13th Jun 2025 07:45

(Alliance News) - The FTSE 100 is set to open lower on Friday, though its oil majors could save it from a deeper decline, as Brent prices jumped following an Israeli strike on Iran's nuclear facilities. Read More

DIRECTOR DEALINGS: Cerillion CEO seeks to sell GBP20 million in shares

12th Jun 2025 13:28

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and Thursday and not separately reported by Alliance News: Read More

IN BRIEF: GSK launches second tranche of GBP2 billion share buyback

4th Jun 2025 08:07

GSK PLC - London-based pharmaceutical company - Starts on Wednesday the second tranche of its previously announced GBP2.0 billion share buyback programme. The new tranche, worth up to GBP450.0 million, follows the completion of a first tranche of GBP700.0 million on Tuesday. Merrill Lynch International will run the second tranche, after Citigroup Global Markets Ltd ran the first. It will be completed by September 19. Shares bought will be held in treasury. Read More

LONDON BRIEFING: UK steel industry welcomes latest tariff decision

4th Jun 2025 07:50

(Alliance News) - Stocks were called higher in the UK on Wednesday, as industry spokespeople cautiously welcome Donald Trump's decision to keep tariffs at 25% on British steel and aluminium for now. Read More

LONDON MARKET CLOSE: Blue chips edge higher amid Wall Street gains

3rd Jun 2025 17:06

(Alliance News) - London's FTSE 100 posted modest gains on Tuesday as US markets rose after encouraging US jobs data, helping offset weak mining stocks and lower growth forecasts from the OECD. Read More

LONDON BROKER RATINGS: Jefferies raises Hiscox, cuts Rio Tinto

3rd Jun 2025 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BRIEFING: FTSE 100 up as UK pushes for tariff reprieve

3rd Jun 2025 07:50

(Alliance News) - Stocks were called to open higher on Tuesday, following claims that trade talks between US President Donald Trump and Chinese President Xi Jinping are imminent. Read More

DIRECTOR DEALINGS: hVIVO CEO buys shares; Investec execs sell stock

2nd Jun 2025 21:45

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News: Read More

LONDON MARKET OPEN: Stocks mixed as UK house price growth speeds up

2nd Jun 2025 09:04

(Alliance News) - Stock prices in London opened mixed on Monday, ahead of the UK's manufacturing PMI reading and following the government's announced commitments to defence spending. Read More

US FDA accepts new drug application for GSK's liver drug linerixibat

2nd Jun 2025 08:29

(Alliance News) - GSK PLC on Monday announced the US Food & Drug Administration has accepted for review the new drug application for its liver disease treatment, linerixibat. Read More

LONDON MARKET CLOSE: FTSE 100 rises despite tariff worries; M&G shines

30th May 2025 17:05

(Alliance News) - The FTSE 100 outperformed in a mixed day for European equities, after the US Court of Appeals temporarily reinstated Donald Trump's tariffs. Read More

GSK ends cUTI trial early as Spero joint product meets efficacy goal

28th May 2025 12:16

(Alliance News) - GSK PLC on Wednesday said it will stop a late-stage trial early for an investigational oral antibiotic to treat complicated urinary tract infections, or cUTIs, after the treatment showed positive results in an interim analysis. Read More

LONDON MARKET CLOSE: Stocks down before long weekend, Powell's speech

23rd May 2025 17:01

(Alliance News) - Stock prices in London closed in the red on Friday, following US President Donald Trump's renewed tariff threats against the EU and Apple. Read More

GSK hails positive EU opinion of blood cancer treatment Blenrep

23rd May 2025 12:49

(Alliance News) - GSK PLC on Friday said its drug Blenrep has received a "positive opinion" from the European Medicines Agency's Committee for Medicinal Products for Human Use. Read More

LONDON MARKET OPEN: European stocks rise as bond yields ease

23rd May 2025 08:56

(Alliance News) - European stocks opened higher on Friday, as a cooling of US yields calmed some investor nerves, while improved UK data boosted sterling. Read More

GSK's Nucala wins FDA approval for COPD with eosinophilic inflammation

23rd May 2025 08:27

(Alliance News) - GSK PLC on Thursday said the US Food & Drug Administration has approved its asthma drug Nucala as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease, or COPD, who have an eosinophilic phenotype. Read More

GSK wins approval in Japan for Blenrep combination as myeloma therapy

19th May 2025 08:20

(Alliance News) - GSK PLC on Monday said it has received approval in Japan for Blenrep combinations in the treatment of adults with relapsed or refractory multiple myeloma. Read More

FTSE 100 Latest

Value9,485.16

Change6.02